- Home
- AMBC vs ORIC Comparison
AMBC vs ORIC Comparison
Compare AMBC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- ORIC
- Stock Information
- Founded
- AMBC 1991
- ORIC 2014
- Country
- AMBC United States
- ORIC United States
- Employees
- AMBC N/A
- ORIC N/A
- Industry
- AMBC Property-Casualty Insurers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- ORIC Health Care
- Exchange
- AMBC Nasdaq
- ORIC Nasdaq
- Market Cap
- AMBC 566.2M
- ORIC 633.7M
- IPO Year
- AMBC 1991
- ORIC 2020
- Fundamental
- Price
- AMBC $12.56
- ORIC $9.59
- Analyst Decision
- AMBC Strong Buy
- ORIC Strong Buy
- Analyst Count
- AMBC 2
- ORIC 9
- Target Price
- AMBC $17.00
- ORIC $18.75
- AVG Volume (30 Days)
- AMBC 696.9K
- ORIC 498.9K
- Earning Date
- AMBC 11-12-2024
- ORIC 11-12-2024
- Dividend Yield
- AMBC N/A
- ORIC N/A
- EPS Growth
- AMBC N/A
- ORIC N/A
- EPS
- AMBC N/A
- ORIC N/A
- Revenue
- AMBC $398,000,000.00
- ORIC N/A
- Revenue This Year
- AMBC N/A
- ORIC N/A
- Revenue Next Year
- AMBC N/A
- ORIC N/A
- P/E Ratio
- AMBC N/A
- ORIC N/A
- Revenue Growth
- AMBC 22.46
- ORIC N/A
- 52 Week Low
- AMBC $10.12
- ORIC $6.33
- 52 Week High
- AMBC $18.45
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- AMBC 62.15
- ORIC 52.76
- Support Level
- AMBC $12.24
- ORIC $8.11
- Resistance Level
- AMBC $12.71
- ORIC $8.90
- Average True Range (ATR)
- AMBC 0.48
- ORIC 0.74
- MACD
- AMBC 0.07
- ORIC -0.04
- Stochastic Oscillator
- AMBC 70.80
- ORIC 49.42
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.